Bank Of Montreal Immunity Bio, Inc. Transaction History
Bank Of Montreal
- $197 Billion
- Q2 2024
A detailed history of Bank Of Montreal transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 2,500 shares of IBRX stock, worth $13,550. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,500
Previous 253,900
99.02%
Holding current value
$13,550
Previous $1.36 Million
98.9%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IBRX
# of Institutions
212Shares Held
63.3MCall Options Held
1.44MPut Options Held
4.01M-
Vanguard Group Inc Valley Forge, PA13.8MShares$75 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$61.9 Million0.0% of portfolio
-
State Street Corp Boston, MA7.86MShares$42.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.92MShares$21.2 Million0.0% of portfolio
-
Jane Street Group, LLC New York, NY1.72MShares$9.3 Million0.01% of portfolio
About ImmunityBio, Inc.
- Ticker IBRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 400,304,000
- Market Cap $2.17B
- Description
- ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...